MarketScreener Homepage > Equities > NASDAQ OMX STOCKHOLM > Probi AB (publ) PROB SE0001280355

Report

Delayed NASDAQ OMX STOCKHOLM - 09/25 11:29:43 am
342.5	SEK		-1.30%

08/27

PROBI : New clinical results on stress from Probi and their probiotic strain L. plantarum, HEAL9

07/17

Q2 2020 : Probi raises long-term financial targets

07/14

PROBI PUBL : Presentation of Probi's Q2 report 2020 and new financial targets

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq Omx Stockholm

09/21/2020	09/22/2020	09/23/2020	09/24/2020	09/25/2020	Date
356.5(c)	357(c)	361.5(c)	347(c)	342.5(c)	Last
4 952	1 729	2 151	5 168	3 838	Volume
-2.60%	+0.14%	+1.26%	-4.01%	-1.30%	Change

More quotes

Financials

Sales 2020	671 M 73,5 M 73,5 M
Net income 2020	92,0 M 10,1 M 10,1 M
Net cash position 2020	284 M 31,1 M 31,1 M
P/E ratio 2020	41,5x
Yield 2020	0,45%

Sales 2021	721 M 79,0 M 79,0 M
Net income 2021	113 M 12,4 M 12,4 M
Net cash position 2021	386 M 42,3 M 42,3 M
P/E ratio 2021	33,7x
Yield 2021	0,63%

Capitalization	3 902 M 427 M 428 M
EV / Sales 2020	5,40x
EV / Sales 2021	4,88x
Nbr of Employees	-
Free-Float	38,9%

More Financials

Company

Probi AB is a Sweden-based company engaged in the probiotics research and development. The Companyâ€™s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies...

Sector

Food Processing

Calendar

10/21

Ergebnisveröffentlichung

More about the company

Notations Surperformance© of Probi AB (publ)

Trading Rating :

Investor Rating :

More Ratings

All news about PROBI AB (PUBL)

08/27	PROBI : New clinical results on stress from Probi and their probiotic strain L. ..	AQ
07/17	Q2 2020 : Probi raises long-term financial targets	AQ
07/14	PROBI PUBL : Presentation of Probi's Q2 report 2020 and new financial targets	PU
07/14	PROBI PUBL : Presentation of Probi's Q2 report 2020 and new financial targets	AQ
07/02	PROBI PUBL : and Örebro University to collaborate on research into exploration o..	AQ
05/14	PROBI PUBL : A true pioneer in probiotic research is elected NutraChampion 2020	AQ
05/14	PROBI AB (PUBL) : Ex-dividend day for final dividend	FA
05/13	PROBI PUBL : ´s Annual General Meeting 2020	PU
05/13	PROBI PUBL : Annual General Meeting 2020	AQ
04/24	Q1 2020 : A solid start to the year	AQ
04/21	PROBI PUBL : Presentation of Probi's Q1 report 2020	PU
04/21	PROBI PUBL : Presentation of Probi's Q1 report 2020	AQ
04/08	PROBI PUBL : publishes Annual and Sustainability Report for 2019	AQ
04/07	PROBI PUBL : Notice to Annual General Meeting in Probi AB (publ)	AQ
03/24	PROBI PUBL : and Viva5 announce strategic joint venture to address growing marke..	AQ

More news

News in other languages on PROBI AB (PUBL)

02/11	PROBI AB (PUBL) : rentabilité renforcée
2019	JPMorgan belässt Symrise auf 'Underweight' - Ziel 63 Euro
2018	PROBI AB : Veröffentlichung des Halbjahresergebnisses
2018	PROBI AB : publication des résultats semestriels
2018	PROBI AB : Veröffentlichung des Jahresergebnisses

More news

Provided by Scoopnest.com

Chart PROBI AB (PUBL)

Duration : Period :

Probi AB (publ) Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends PROBI AB (PUBL)

	Short Term	Mid-Term	Long Term
Trends	Neutral	Bullish	Bullish

Technical analysis

Income Statement Evolution

More Financials

Consensus

Mean consensus	-
Number of Analysts	2
Average target price	420,00 SEK
Last Close Price	342,50 SEK
Spread / Highest target	22,6%
Spread / Average Target	22,6%
Spread / Lowest Target	22,6%

Consensus

EPS Revisions

More Estimates Revisions

Managers

Name	Title
Tom Juhani Rönnlund	Chief Executive Officer
Jean-Yves Parisot	Chairman
Andy McShea	Vice President-Operations
Henrik Lundkvist	Chief Financial Officer
Niklas Brandt	Vice President-Information Technology

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

PROBI AB (PUBL)	54.28%	427



BY-HEALTH CO., LTD.	26.76%	4 785
BALCHEM CORPORATION	-5.88%	3 094
THE SIMPLY GOOD FOODS COMPANY	-23.72%	2 076
MEDIFAST, INC.	50.48%	1 931
JAMIESON WELLNESS INC.	55.88%	1 187

More Results